tiprankstipranks
Trending News
More News >
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$24.90
HK$10.49B
13.74
-3.53%
Ascletis Pharma, Inc.
HK$13.13
HK$12.95B
-46.07
505.07%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$5.32
HK$9.81B
-47.25
62.20%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$15.06B
-53.18
61.66%
4 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.54
HK$8.60B
-14.62
50.67%
0 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$25.76
HK$10.48B
71.50
218.02%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
24.90
-0.91
-3.53%
HK:1672
Ascletis Pharma, Inc.
13.13
10.67
433.74%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.32
2.18
69.43%
HK:2162
Keymed Biosciences, Inc.
54.40
21.50
65.35%
HK:2171
CARsgen Therapeutics Holdings Ltd.
14.54
5.85
67.32%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
25.76
17.38
207.40%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts